Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCB0942 drug-drug interaction study with carbamazepine, lamotrigine, or levetiracetam in adults with epilepsy
NL-OMON57814Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of padsevonil in epilepsy (3 cohorts), sponsored by Centre for Human Drug Research. Primary endpoints: Trough plasma concentration of carbamazepine-epoxide and Ratio of trough carbamazepine-epoxide to trough carbamazepine concentration. Started Sep 2012; status: completed.
02
Drugs
padsevonil
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON57814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57814.